Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
Mintz advised Immunome, and Cooley and Goodwin advised Morphimmune. Immunome (Nasdaq: IMNM) and Morphimmune announced that they have entered into a definitive merger agreement. The Boards of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Fulcrum Therapeutics on the deal. Fulcrum Therapeutics, Inc. (Nasdaq: FULC) announced its underwritten public offering of 9,615,384 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
DS Avocats advised Menissez Group on the deal. Meninez, a French industrial bakery supplier, has finalized the signing, alongside 9 other manufacturers, of a new electricity...
You must be a Standard 1 Year member to access this content.
